TrialOphthalmology2020

Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial.

Rebecca N Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.